Gilead’s $11.9 billion purchase of Kite Pharma in 2017 didn’t follow the script, with two big write-downs in the value of the asset since then, but a fresh approval for a CAR-T therapy could ...

Gilead has also been building its oncology pipeline thanks to its acquisition of Kite Pharma which markets cutting-edge CAR-T cancer cell therapies. Immunotherapy is an area where AZ faces tough ...

Signage is pictured in the main lobby of GSK offices in London, Britain, February 20, 2025. REUTERS/Chris J. Ratcliffe GSK said on Tuesday that it is studying a group of more than a million older ...

US and Ukrainian officials have begun talks in Saudi Arabia to find a way to end the war with Russia. Video shows officials from Ukraine and the United States meeting in Saudi Arabia at the start ...

Story Jan. 10 - Shoreline Biosciences: The cell therapy biotech plans to let go of an undisclosed number of employees tied to a project with Gilead Sciences’ Kite Pharma. Story Jan. 9 - IGM ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,864.33 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...

As 2024 ends, the world braces for a shifting geopolitical landscape with potential changes in power dynamics.

IPC Indice de Precios Y Cotizaciones 52,937.61 265.19 0.50% ...

VistaShares Co-Founder Jon McNeill discusses the VistaShares Artificial Intelligence Supercycle ETF (ticker: AIS). He explains a supercylcle, which he says currently includes AI, electrification ...

21 March 2025 China's burgeoning biotech R&D capabilities are attracting increasing international attention, with non-Western countries actively seeking partnerships. At the BIOCHINA event in Suzhou ...